Harrow (HROW) News Today → Bible Shocker: Have You Seen Elon Musk’s Miracle? (From InvestorPlace) (Ad) Free HROW Stock Alerts $16.76 +0.60 (+3.71%) (As of 05/17/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 19 at 6:24 AM | americanbankingnews.comHarrow (NASDAQ:HROW) Shares Up 5.9%May 19 at 5:50 AM | americanbankingnews.comHarrow (NASDAQ:HROW) Price Target Raised to $26.00May 17 at 8:45 PM | marketbeat.comHarrow, Inc. (NASDAQ:HROW) Sees Large Drop in Short InterestHarrow, Inc. (NASDAQ:HROW - Get Free Report) was the recipient of a significant drop in short interest in the month of April. As of April 30th, there was short interest totalling 5,500,000 shares, a drop of 7.1% from the April 15th total of 5,920,000 shares. Based on an average daily volume of 462,100 shares, the days-to-cover ratio is currently 11.9 days.May 17 at 5:06 PM | marketbeat.comHarrow (NASDAQ:HROW) Trading Up 5.9%Harrow (NASDAQ:HROW) Trading 5.9% HigherMay 17 at 6:39 AM | americanbankingnews.comHarrow (NASDAQ:HROW) Rating Reiterated by B. RileyMay 17 at 2:44 AM | americanbankingnews.comQ2 2024 Earnings Forecast for Harrow, Inc. Issued By B. Riley (NASDAQ:HROW)May 16 at 7:26 AM | marketbeat.comQ2 2024 EPS Estimates for Harrow, Inc. Decreased by B. Riley (NASDAQ:HROW)Harrow, Inc. (NASDAQ:HROW - Free Report) - Research analysts at B. Riley lowered their Q2 2024 earnings per share estimates for shares of Harrow in a research note issued to investors on Tuesday, May 14th. B. Riley analyst M. Mamtani now anticipates that the company will post earnings per share oMay 16 at 3:02 AM | americanbankingnews.comHarrow, Inc. (NASDAQ:HROW) Expected to Earn Q4 2024 Earnings of $0.17 Per ShareMay 15, 2024 | marketbeat.comCraig Hallum Increases Harrow (NASDAQ:HROW) Price Target to $26.00Craig Hallum upped their price target on Harrow from $24.00 to $26.00 and gave the stock a "buy" rating in a research note on Wednesday.May 15, 2024 | insidermonkey.comHarrow Health, Inc. (NASDAQ:HROW) Q1 2024 Earnings Call TranscriptMay 15, 2024 | marketbeat.comHarrow (NASDAQ:HROW) Earns "Buy" Rating from B. RileyB. Riley reissued a "buy" rating and set a $29.00 price objective (up previously from $26.00) on shares of Harrow in a research report on Wednesday.May 15, 2024 | marketbeat.comEquities Analysts Set Expectations for Harrow, Inc.'s Q4 2024 Earnings (NASDAQ:HROW)Harrow, Inc. (NASDAQ:HROW - Free Report) - Equities researchers at B. Riley increased their Q4 2024 earnings estimates for Harrow in a research note issued to investors on Tuesday, May 14th. B. Riley analyst M. Mamtani now expects that the company will earn $0.17 per share for the quarter, up froMay 15, 2024 | businesswire.comHarrow to Present at Two Investor Conferences in MayMay 15, 2024 | finance.yahoo.comHarrow Inc (HROW) Q1 2024 Earnings Call Transcript Highlights: Robust Growth and Strategic AdvancesMay 15, 2024 | finance.yahoo.comHarrow, Inc. (HROW) Stock Price, News, Quote & History - Yahoo FinanceMay 15, 2024 | markets.businessinsider.comHarrow Health’s Promising Growth Trajectory and Strong Financial Outlook Reinforce Buy RatingMay 14, 2024 | marketbeat.comHarrow (NASDAQ:HROW) Shares Gap Up to $12.07Harrow (NASDAQ:HROW) Shares Gap Up to $12.07May 14, 2024 | seekingalpha.comHarrow, Inc. 2024 Q1 - Results - Earnings Call PresentationMay 13, 2024 | investorplace.comHROW Stock Earnings: Harrow Health Misses EPS, Misses Revenue for Q1 2024May 13, 2024 | markets.businessinsider.comCraig-Hallum Keeps Their Buy Rating on Harrow Health (HROW)May 13, 2024 | businesswire.comHarrow Announces First Quarter 2024 Financial ResultsMay 13, 2024 | businesswire.comHarrow Names Greg DiPasquale as Senior Vice President, Head of CommercialMay 11, 2024 | americanbankingnews.comHarrow (HROW) Scheduled to Post Earnings on MondayMay 10, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Rapid Micro Biosystems (RPID), COMPASS Pathways (CMPS) and Harrow Health (HROW)May 6, 2024 | marketbeat.comHarrow Health (HROW) Scheduled to Post Quarterly Earnings on MondayHarrow Health (NASDAQ:HROW) will be releasing earnings after the market closes on Monday, May 13, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=589316)May 2, 2024 | seekingalpha.comHarrow: Merits A Buy On Sales PotentialMay 2, 2024 | seekingalpha.comHarrow: The Bull Thesis Is On Track, But Short-Term Challenges LoomApril 26, 2024 | insidertrades.comHarrow Health, Inc. (NASDAQ:HROW) Major Shareholder Purchases $199,400.00 in StockApril 25, 2024 | marketbeat.comInsider Buying: Harrow Health, Inc. (NASDAQ:HROW) Major Shareholder Buys 20,000 Shares of StockHarrow Health, Inc. (NASDAQ:HROW - Get Free Report) major shareholder Opaleye Management Inc. purchased 20,000 shares of the stock in a transaction on Thursday, April 25th. The stock was acquired at an average price of $9.97 per share, with a total value of $199,400.00. Following the acquisition, the insider now directly owns 3,815,000 shares in the company, valued at $38,035,550. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Major shareholders that own more than 10% of a company's stock are required to disclose their transactions with the SEC.April 25, 2024 | businesswire.comHarrow Will Release First Quarter 2024 Financial Results After Market Close on May 13, 2024April 25, 2024 | insidertrades.comOpaleye Management Inc. Purchases 11,715 Shares of Harrow Health, Inc. (NASDAQ:HROW) StockApril 24, 2024 | marketbeat.comHarrow Health, Inc. (NASDAQ:HROW) Major Shareholder Opaleye Management Inc. Purchases 11,715 SharesHarrow Health, Inc. (NASDAQ:HROW - Get Free Report) major shareholder Opaleye Management Inc. bought 11,715 shares of Harrow Health stock in a transaction dated Tuesday, April 23rd. The stock was acquired at an average cost of $10.29 per share, for a total transaction of $120,547.35. Following the completion of the transaction, the insider now directly owns 3,786,715 shares in the company, valued at $38,965,297.35. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Large shareholders that own more than 10% of a company's shares are required to disclose their sales and purchases with the SEC.April 21, 2024 | insidertrades.comOpaleye Management Inc. Acquires 29,400 Shares of Harrow Health, Inc. (NASDAQ:HROW) StockApril 20, 2024 | finance.yahoo.comHarrow, Inc. (HROW)April 19, 2024 | marketbeat.comInsider Buying: Harrow Health, Inc. (NASDAQ:HROW) Major Shareholder Purchases 29,400 Shares of StockHarrow Health, Inc. (NASDAQ:HROW - Get Free Report) major shareholder Opaleye Management Inc. bought 29,400 shares of Harrow Health stock in a transaction dated Friday, April 19th. The stock was purchased at an average price of $10.56 per share, with a total value of $310,464.00. Following the purchase, the insider now directly owns 3,775,000 shares in the company, valued at approximately $39,864,000. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Large shareholders that own more than 10% of a company's stock are required to disclose their transactions with the SEC.April 13, 2024 | marketbeat.comVanguard Group Inc. Has $25.29 Million Stock Holdings in Harrow Health, Inc. (NASDAQ:HROW)Vanguard Group Inc. raised its stake in Harrow Health, Inc. (NASDAQ:HROW - Free Report) by 5.7% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 1,759,879 shares of the company's stock after buying an additional 95,389 shares during the quaApril 11, 2024 | marketbeat.comHarrow Health (NASDAQ:HROW) Now Covered by Craig HallumCraig Hallum assumed coverage on Harrow Health in a research note on Thursday. They issued a "buy" rating and a $24.00 price objective for the company.April 3, 2024 | bizjournals.comMelt Pharmaceuticals raises $24 million for drug developmentApril 2, 2024 | finance.yahoo.comMelt Pharmaceuticals Closes $24 Million Series B Preferred Stock FinancingMarch 29, 2024 | insidertrades.comOpaleye Management Inc. Acquires 50,000 Shares of Harrow Health, Inc. (NASDAQ:HROW) StockMarch 28, 2024 | marketbeat.comHarrow Health, Inc. (NASDAQ:HROW) Major Shareholder Purchases $641,000.00 in StockHarrow Health, Inc. (NASDAQ:HROW - Get Free Report) major shareholder Opaleye Management Inc. purchased 50,000 shares of the business's stock in a transaction dated Thursday, March 28th. The shares were acquired at an average cost of $12.82 per share, for a total transaction of $641,000.00. Following the acquisition, the insider now owns 3,745,600 shares of the company's stock, valued at approximately $48,018,592. The acquisition was disclosed in a filing with the SEC, which is accessible through the SEC website. Major shareholders that own at least 10% of a company's stock are required to disclose their sales and purchases with the SEC.March 26, 2024 | insidertrades.comMark L. Baum Acquires 9,000 Shares of Harrow Health, Inc. (NASDAQ:HROW) StockMarch 25, 2024 | marketbeat.comInsider Buying: Harrow Health, Inc. (NASDAQ:HROW) CEO Acquires 9,000 Shares of StockHarrow Health, Inc. (NASDAQ:HROW - Get Free Report) CEO Mark L. Baum purchased 9,000 shares of the company's stock in a transaction that occurred on Friday, March 22nd. The stock was acquired at an average price of $11.59 per share, for a total transaction of $104,310.00. Following the purchase, the chief executive officer now owns 2,137,525 shares in the company, valued at approximately $24,773,914.75. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.March 25, 2024 | marketbeat.comB. Riley Cuts Harrow Health (NASDAQ:HROW) Price Target to $26.00B. Riley reduced their price target on Harrow Health from $30.00 to $26.00 and set a "buy" rating on the stock in a research report on Friday.March 23, 2024 | insidertrades.comOpaleye Management Inc. Acquires 50,600 Shares of Harrow Health, Inc. (NASDAQ:HROW) StockMarch 22, 2024 | marketbeat.comHarrow Health, Inc. (NASDAQ:HROW) Major Shareholder Opaleye Management Inc. Buys 50,600 SharesHarrow Health, Inc. (NASDAQ:HROW - Get Free Report) major shareholder Opaleye Management Inc. acquired 50,600 shares of the business's stock in a transaction on Wednesday, March 20th. The shares were bought at an average price of $9.65 per share, with a total value of $488,290.00. Following the completion of the transaction, the insider now directly owns 3,695,600 shares of the company's stock, valued at $35,662,540. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Major shareholders that own at least 10% of a company's shares are required to disclose their transactions with the SEC.March 21, 2024 | finance.yahoo.comHarrow Health, Inc. (NASDAQ:HROW) Q4 2023 Earnings Call TranscriptMarch 20, 2024 | investorplace.comWhy Is Harrow (HROW) Stock Up 5% Today?March 20, 2024 | seekingalpha.comHarrow, Inc. 2023 Q4 - Results - Earnings Call PresentationMarch 20, 2024 | msn.comHarrow Health Non-GAAP EPS of -$0.20 misses by $0.15, revenue of $36.36M misses by $1.5M Get Harrow News Delivered to You Automatically Sign up to receive the latest news and ratings for HROW and its competitors with MarketBeat's FREE daily newsletter. Email Address Bible Shocker: Have You Seen Elon Musk’s Miracle? (Ad)Breaking News: Elon Musk Invents New Type of A.I. (Shocking) Elon Musk is about to shock the world again with this new type of A.I.… Minting new millionaires in the process. Click here for the full story… HROW Media Mentions By Week HROW Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HROW News Sentiment▼0.210.42▲Average Medical News Sentiment HROW News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HROW Articles This Week▼332▲HROW Articles Average Week Get Harrow News Delivered to You Automatically Sign up to receive the latest news and ratings for HROW and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Olema Pharmaceuticals News Avid Bioservices News COMPASS Pathways News SIGA Technologies News Altimmune News Stoke Therapeutics News Phathom Pharmaceuticals News IGM Biosciences News Arbutus Biopharma News Aerovate Therapeutics News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:HROW) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersBill Gates is all about this tiny $2 stockTimothy SykesCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingDems have chosen Biden replacement?Paradigm PressMan who spotted Apple at $1.49 says: “Buy These 6 AI Stocks.”InvestorPlaceForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the Markets[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsBuy this small stock before coming AI Tidal WaveChaikin AnalyticsShocking $16T Elon Musk Crypto LeakCrypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Harrow, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
